Article
Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
Lung cancer (Amsterdam, Netherlands) - 1 Jan 2000
Yin L, Pu Y, Liu T Y, Tung Y H, Chen K W, Lin P
Abstract excerpt
Genetic variations in metabolic activation or detoxification enzymes have been thought to contribute to individual differences in lung cancer susceptibility. Genetic polymorphisms of NAD(P)H quinone oxidoreductase (NQO1), cytochrome P4501A1 (CYP1A1) and microsomal epoxide hydrolase (HYL1) have been associated with increased lung cancer risk in Asian populations. In the present study, the possibility of an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
